Proteomics is a rapidly growing field that involves the study of all the proteins present in a biological system. It is an essential part of the life sciences industry, and its applications are expanding across a wide range of industries, including healthcare, pharmaceuticals, biotechnology, and research and development.
The global proteomics market size was valued at USD 19.49 billion in 2021 and is projected to reach USD 38.36 billion by 2028, growing at a CAGR of 9.7% from 2021 to 2028. The market growth is driven by the increasing demand for personalized medicine and the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases.
The market is segmented based on technology, application, and region. Based on technology, the market is segmented into mass spectrometry, electrophoresis, chromatography, protein microarrays, and others. Mass spectrometry is the largest segment in terms of market share due to its accuracy, sensitivity, and high throughput capabilities.
Based on application, the market is segmented into drug discovery, clinical diagnostics, protein identification, biomarker discovery, and others. Drug discovery is the largest segment due to the increasing demand for new and effective drugs for the treatment of various diseases.
Geographically, North America is the largest market for proteomics due to the presence of a large number of pharmaceutical and biotechnology companies, increasing government funding, and growing research and development activities. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period due to the increasing investments by governments and private organizations in the life sciences industry.
The key players operating in the market include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Waters Corporation, Bio-Rad Laboratories, Inc., GE Healthcare, Danaher Corporation, Bruker Corporation, Luminex Corporation, PerkinElmer, Inc., and Creative Proteomics. These companies are adopting various strategies such as mergers and acquisitions, partnerships, collaborations, and product launches to strengthen their market position and expand their product portfolios.
In conclusion, the global proteomics market is expected to witness significant growth in the coming years due to the increasing demand for personalized medicine, the rising prevalence of chronic diseases, and the increasing investments in the life sciences industry. The market is highly competitive, and the key players are focusing on product development and strategic collaborations to maintain their market position.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Market Insight Lab journalist was involved in the writing and production of this article.